| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/18/2002 | WO2001027277A3 Proteins and polynucleotides encoded thereby |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2001025420A3 Adjustable sensitivity, genetic molecular interaction systems, including protein-protein interaction systems for detection and analysis |
| 04/18/2002 | WO2001018245A3 Detection of alterations in a gene by long range pcr using human mobile elements |
| 04/18/2002 | WO2000073482A9 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 04/18/2002 | WO2000072887A9 A novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors |
| 04/18/2002 | WO2000071752A9 Assay for the detection of paclitaxel resistant cells in human tumors |
| 04/18/2002 | WO2000071722A9 Novel genes to control flowering, transgenic plants, and uses thereof |
| 04/18/2002 | WO2000070341A9 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 04/18/2002 | WO2000070073A9 Method for sequencing nucleic acid molecules |
| 04/18/2002 | WO2000070044A9 Human brain t calcium channel alpha-subunit splice variants |
| 04/18/2002 | WO2000069454A9 Suppression of endogenous igfbp-2 to inhibit cancer |
| 04/18/2002 | WO2000068411A9 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 04/18/2002 | WO2000068387A9 Nucleic acids and proteins with interferon-beta activity |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | WO2000067793A9 Death domain containing receptor 4 |
| 04/18/2002 | WO2000055192A3 Hemocyanin and nucleic acid sequence coding for the same |
| 04/18/2002 | US20020046419 Introducing an engineered zinc finger polypeptide in said plant cell which polypeptide binds to the target DNA and modulates transcription of the coding sequence |
| 04/18/2002 | US20020046418 In transgenic plants transformed with an expression vector comprising a controlled environment agriculture (CEA) promoter operably linked to a gene encoding the heterologous protein of interest, to maximize heterologous protein production |
| 04/18/2002 | US20020046417 Development of resistance to raspberry bushy dwarf virus |
| 04/18/2002 | US20020046416 Plant proteins |
| 04/18/2002 | US20020046415 Plant promoter sequences and methods of use thereof |
| 04/18/2002 | US20020046414 In vivo electroporation method for early stage embryo of aves |
| 04/18/2002 | US20020046413 Transgenic mice containing BMP gene disruptions |
| 04/18/2002 | US20020046412 Use for finding active compounds for crop protection |
| 04/18/2002 | US20020046410 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 04/18/2002 | US20020046409 Roles for Nkx3.1 in prostate development and cancer |
| 04/18/2002 | US20020045990 Method and system for searching for relationships between base sequences in genes |
| 04/18/2002 | US20020045743 Novel human membrane proteins and polynucleotides encoding the same |
| 04/18/2002 | US20020045740 Novel human 7TM proteins and polynucleotides encoding the same |
| 04/18/2002 | US20020045739 Acyl glucosaminyl inositol amidase family and methods of use |
| 04/18/2002 | US20020045738 Oligonucleotide-binding e-tag probe compositions |
| 04/18/2002 | US20020045737 Enterococcus faecalis polynucleotides and polypeptides |
| 04/18/2002 | US20020045734 Geneticaly engineered polypeptide for use drug delivery tools |
| 04/18/2002 | US20020045589 Hirulogs are a group of synthetic thrombin-specific inhibitors which conserve the major active sites of hirudin; treatment of vascular restenosis |
| 04/18/2002 | US20020045588 Telomerase Reverse Transcriptase (TERT); treatment of cancer; modulating apoptosis |
| 04/18/2002 | US20020045587 Attenuated bacteria transformed with a promoter activated in cytosol of a host cell to produce a polypeptide lethal to the bacterium, and a host cell compatible promoter coding for therapeutic polypeptide such as an antigen; vaccination |
| 04/18/2002 | US20020045577 Human schizophrenia gene |
| 04/18/2002 | US20020045568 Use of mp52 0r mp121 for treating and preventing diseases of the nervous system |
| 04/18/2002 | US20020045567 Synthetic proteins for in vivo drug delivery and tissue augmentation |
| 04/18/2002 | US20020045551 4-benzoyl isoxazoles derivatives and their use as herbicides |
| 04/18/2002 | US20020045276 Analyte assay using particulate labels |
| 04/18/2002 | US20020045273 Test methods and devices |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020045263 Biodegradable particles for use in time release agents and gene therapy |
| 04/18/2002 | US20020045257 Forming embryonic germ cells useful as model for studying imprinting; mate mammals, obtain embryo, dissociate embryonic cells, culturing the dissociated cells |
| 04/18/2002 | US20020045255 Method of making glycoprotein exhibiting erythropoiesis regulating activity and glycoprotein produced by this method |
| 04/18/2002 | US20020045254 Established cells |
| 04/18/2002 | US20020045253 Isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines |
| 04/18/2002 | US20020045250 Generating adenovirus associated viral plasmid; obtain cell, incubate with helper virus, generate recombinant viral particle, recover plasmid |
| 04/18/2002 | US20020045249 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 04/18/2002 | US20020045248 Intracellular inhibitors of gq protein signaling |
| 04/18/2002 | US20020045247 Expression vector for use in human and primate gene therapy |
| 04/18/2002 | US20020045241 T cells specific for kidney carcinoma |
| 04/18/2002 | US20020045239 Transducing phages |
| 04/18/2002 | US20020045238 Thermostable D-hydantoinase and the application thereof |
| 04/18/2002 | US20020045237 Bacterial two-hybrid system for protein-protein interaction screening, new strains for use therein, and their applications |
| 04/18/2002 | US20020045236 Nucleotide sequences coding enzymatic polypeptide; for use in water treatment and bioremediation of soils |
| 04/18/2002 | US20020045234 Expression system |
| 04/18/2002 | US20020045232 For producing a cell capable of generating conjugated linoleic acid or linolenic acid |
| 04/18/2002 | US20020045229 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 04/18/2002 | US20020045224 Nucleotide sequences coding phosphoenol pyruvate synthase; for use in the generation of lysine; for use in food processing |
| 04/18/2002 | US20020045223 Microorganism for use in the generation of preferential amino acid in culture |
| 04/18/2002 | US20020045220 Biosynthesis of polyketide synthase substrates |
| 04/18/2002 | US20020045219 Generating hybrid cell expresses telomerase; obtain cells, fuse, transform cells, monitor cell for expression of telomerase |
| 04/18/2002 | US20020045217 Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 04/18/2002 | US20020045214 Rat G-protein coupled receptor AXOR29 |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | US20020045212 Nucleotide sequences coding preferential polypeptides for use in the treatment of alzheimer's, parkinson's, autoimmune, psoraisis, leukemia, infections, and skin disorders |
| 04/18/2002 | US20020045211 Plasmid for use in the generation of genetically engineered amino acid sequences |
| 04/18/2002 | US20020045209 Nucleotide sequences coding membrane proteins for treatment of central nervous system disorder |
| 04/18/2002 | US20020045208 Nucleotide sequences which code polypeptides for use in treatment of autoimmune diseases, allergies and tumors |
| 04/18/2002 | US20020045207 Glycoprotein production process |
| 04/18/2002 | US20020045206 Contacting the cells with a trophic amount of a ptc therapeutic for promoting survival of substantia nigra neuronal cells |
| 04/18/2002 | US20020045205 Method for autoactivation of procaspase 8 |
| 04/18/2002 | US20020045202 Enzymatic polypeptide for use in diagnosis, prevention and treatment of inflammatory defects, cancer, diabetes |
| 04/18/2002 | US20020045201 Sreening drugs for use in treatment of nervous system disorders; obtain protein sample, mix with modulator, monitor complex formation, compare to control, adjustment in concentration of preferential complex indicates modulator |
| 04/18/2002 | US20020045193 Polypeptide for use in purifying and separation of target peptides |
| 04/18/2002 | US20020045188 Methods for validating polypeptide targets that correlate to cellular phenotypes |
| 04/18/2002 | US20020045185 Secreted neural adhesion proteins |
| 04/18/2002 | US20020045183 Methods for detecting mutations using primer extension |
| 04/18/2002 | US20020045181 Method for displaying result of hybridization experiment using biochip and method for evaluating experimental error of hybridization experiment |
| 04/18/2002 | US20020045180 Useful as substrates for polymerase enzymes; used in preparing fluorescently-labeled nucleotides useful as substrates for thermostable polymerases |
| 04/18/2002 | US20020045179 Generating chemical profile in cells; obtain mammalian cells, incubate with chemical intermediate, monitor adjustments in gene and protein expression, generate profile |
| 04/18/2002 | US20020045177 Cloning preferential genes; obtain cells, transform, express preferential genes in cells, monitor activity of genes in biosynthetic process |
| 04/18/2002 | US20020045175 Detecting genetic adjustment in preferential nucleotide sequences; obtain sequences, detect linkage positions, detect genetic adjustment, generate profile, detect mutants in genetic adjustment |
| 04/18/2002 | US20020045174 Gene sequencer and method for determining the nucleotide sequence of a chromosome |
| 04/18/2002 | US20020045167 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay |
| 04/18/2002 | US20020045166 Peptides; for use as tools in gene therapy |
| 04/18/2002 | US20020045165 Detecting target nucleotide sequences in sample; obtain sample, incubate sample with preferential nucleotides, detect bound sequences, classify sample |
| 04/18/2002 | US20020045164 Reagents and methods useful for detecting diseases of the lung |
| 04/18/2002 | US20020045160 Fluorescence detection |
| 04/18/2002 | US20020045158 Cells for drug discovery |
| 04/18/2002 | US20020044958 Disaccharide protector; frozen; preserved for longer than one year; shows excellent restoration ability in water |
| 04/18/2002 | US20020044950 Recombinant toxin fragments |
| 04/18/2002 | US20020044946 12-25 kDa bacterial proteins and their 116-58 kDa polymers useful in anti-tumor vaccines |
| 04/18/2002 | US20020044944 DNA encoding the polypeptide, with at least one deletion in the amino acid sequence; expression vectors; host cells; higher apoptosis activity |
| 04/18/2002 | US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy |
| 04/18/2002 | US20020044925 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 04/18/2002 | US20020044919 Combinations and methods for treating neoplasms |